Cullen Investment Group, Ltd. Novartis Ag Transaction History
Cullen Investment Group, Ltd.
- $659 Billion
- Q1 2025
A detailed history of Cullen Investment Group, Ltd. transactions in Novartis Ag stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 5,401 shares of NVS stock, worth $610,745. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,401
Previous 5,611
3.74%
Holding current value
$610,745
Previous $546 Million
10.26%
% of portfolio
0.09%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding NVS
# of Institutions
1,503Shares Held
129MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.38 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.25 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$925 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$777 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$631 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $243B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...